3,3′-Diindolylmethane Protects against Cardiac Hypertrophy via 5′-Adenosine Monophosphate-Activated Protein Kinase-α2
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
3,3′-Diindolylmethane Protects against Cardiac Hypertrophy via 5′-Adenosine Monophosphate-Activated Protein Kinase-α2
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 1, Pages e53427
Publisher
Public Library of Science (PLoS)
Online
2013-01-10
DOI
10.1371/journal.pone.0053427
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative stress and cardiac hypertrophy: a review
- (2012) Subir Kumar Maulik et al. TOXICOLOGY MECHANISMS AND METHODS
- 3,3′-Diindolylmethane but not indole-3-carbinol activates Nrf2 and induces Nrf2 target gene expression in cultured murine fibroblasts
- (2011) I. M. A. Ernst et al. FREE RADICAL RESEARCH
- AMP Activated Protein Kinase-α2 Regulates Expression of Estrogen-Related Receptor-α, a Metabolic Transcription Factor Related to Heart Failure Development
- (2011) Xinli Hu et al. HYPERTENSION
- Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload
- (2011) Heng Zhou et al. PLoS One
- AMPK in cardiovascular health and disease
- (2010) Najeeb A Shirwany et al. ACTA PHARMACOLOGICA SINICA
- AMPK inhibition in health and disease
- (2010) Benoit Viollet et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Novel regulators and drug targets of cardiac hypertrophy
- (2010) Piet Finckenberg et al. JOURNAL OF HYPERTENSION
- Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload
- (2010) H. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AMP-activated protein kinase in contraction regulation of skeletal muscle metabolism: necessary and/or sufficient?
- (2009) T. E. Jensen et al. Acta Physiologica
- Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress
- (2009) Jinqing Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 3,3'-Diindolylmethane Induction of p75NTR-Dependent Cell Death via the p38 Mitogen-Activated Protein Kinase Pathway in Prostate Cancer Cells
- (2009) F. S. Khwaja et al. Cancer Prevention Research
- Mammalian Target of Rapamycin Is a Critical Regulator of Cardiac Hypertrophy in Spontaneously Hypertensive Rats
- (2009) Will Soesanto et al. HYPERTENSION
- LIM and Cysteine-Rich Domains 1 Regulates Cardiac Hypertrophy by Targeting Calcineurin/Nuclear Factor of Activated T Cells Signaling
- (2009) Zhou-Yan Bian et al. HYPERTENSION
- Antiangiogenic Effects of Indole-3-Carbinol and 3,3′-Diindolylmethane Are Associated with Their Differential Regulation of ERK1/2 and Akt in Tube-Forming HUVEC
- (2009) Kazuhiro Kunimasa et al. JOURNAL OF NUTRITION
- Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy
- (2009) Kaie Ojamaa VASCULAR PHARMACOLOGY
- Nuclear Factor E2-Related Factor 2-Dependent Myocardiac Cytoprotection Against Oxidative and Electrophilic Stress
- (2008) Hong Zhu et al. Cardiovascular Toxicology
- AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in Mice
- (2008) Ping Zhang et al. HYPERTENSION
- Molecular regulation of cardiac hypertrophy
- (2008) Sean P. Barry et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Chemoprevention of Pancreatic Cancer: Characterization of Par-4 and its Modulation by 3,3′ Diindolylmethane (DIM)
- (2008) Asfar Sohail Azmi et al. PHARMACEUTICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search